The fourth COVID-19 vaccine reduces the risk of death by 72% amongst the elderly

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccine is effective in protecting the elderly population in long-term care facilities from the Omicron variant. The groundbreaking study included approximately 40,000 elderly Israelis living in institutions supervised by the
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news